Conexeu Sciences Inc. (CNXU)
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Industry: Biotechnology
Conexeu Sciences Inc.
NASDAQ:CNXUHealthcare · Biotechnology
-6.06%$3.10
AH Close$3.31+6.77%vs close
AH Close$3.31+6.77%vs close
Mkt Cap$95.58M
Float14.71M
O/S30.83M
Inst Own0.1%
SI1.4%
Dilution
MCap$95.58M
Float14.71M
O/S30.83M
Dilution